DE69124235D1 - Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins - Google Patents

Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins

Info

Publication number: DE69124235D1
Authority: DE; Germany
Prior art keywords: pertactin; cleaning; bordetella pertussis; membrane protein; purified
Prior art date: 1990-04-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69124235T

Other languages

English (en)

Other versions

DE69124235T3 (de

DE69124235T2 (de

Inventor

Gail Jackson

Raafat Fahim

Larry Tan

Pele Chong

John Vose

Michel Klein

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Pasteur Inc

Original Assignee

Connaught Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-04

Filing date

1991-04-03

Publication date

1997-02-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10673904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69124235(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-04-03 Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd

1997-02-27 Publication of DE69124235D1 publication Critical patent/DE69124235D1/de

1997-05-28 Application granted granted Critical

1997-05-28 Publication of DE69124235T2 publication Critical patent/DE69124235T2/de

2004-06-03 Publication of DE69124235T3 publication Critical patent/DE69124235T3/de

2011-04-04 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE69124235T 1990-04-04 1991-04-03 Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins Expired - Lifetime DE69124235T3 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB909007657A GB9007657D0 (en)	1990-04-04	1990-04-04	Purification of a pertussis outer membrane protein(omp69)
GB9007657		1990-04-04
PCT/CA1991/000110 WO1991015505A1 (en)	1990-04-04	1991-04-03	Purification of a pertussis outer membrane protein

Publications (3)

Publication Number	Publication Date
DE69124235D1 true DE69124235D1 (de)	1997-02-27
DE69124235T2 DE69124235T2 (de)	1997-05-28
DE69124235T3 DE69124235T3 (de)	2004-06-03

Family

ID=10673904

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE0761230T Pending DE761230T1 (de)	1990-04-04	1991-04-03	Aus Bordetella pertussis Aussenmembranprotein enthaltender Impfstoffe und Verfahren zu seiner Herstellung
DE69124235T Expired - Lifetime DE69124235T3 (de)	1990-04-04	1991-04-03	Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
DE0527753T Pending DE527753T1 (de)	1990-04-04	1991-04-03	Reinigung eines pertussisaussenmembranproteines.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE0761230T Pending DE761230T1 (de)	1990-04-04	1991-04-03	Aus Bordetella pertussis Aussenmembranprotein enthaltender Impfstoffe und Verfahren zu seiner Herstellung

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE0527753T Pending DE527753T1 (de)	1990-04-04	1991-04-03	Reinigung eines pertussisaussenmembranproteines.

Country Status (11)

Country	Link
US (2)	US5444159A (de)
EP (2)	EP0761230A3 (de)
JP (1)	JP2549225B2 (de)
AT (1)	ATE147754T1 (de)
CA (1)	CA2079887C (de)
DE (3)	DE761230T1 (de)
DK (1)	DK0527753T4 (de)
ES (2)	ES2104535T1 (de)
GB (1)	GB9007657D0 (de)
GR (2)	GR3022769T3 (de)
WO (1)	WO1991015505A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8412207D0 (en) *	1984-05-12	1984-06-20	Wellcome Found	Antigenic preparations
GB8910570D0 (en)	1989-05-08	1989-06-21	Wellcome Found	Acellular vaccine
US6197548B1 (en)	1990-04-02	2001-03-06	Medeva Pharma Limited	Transformed Pichia expressing the pertactin antigen
NL9002092A (nl) *	1990-09-25	1992-04-16	Nederlanden Staat	Vaccin, geschikt voor de bestrijding van bordetella pertussis.
US6444211B2 (en) *	1991-04-03	2002-09-03	Connaught Laboratories, Inc.	Purification of a pertussis outer membrane protein
GB9304399D0 (en) *	1993-03-04	1993-04-21	Smithkline Beecham Biolog	Novel process
ES2136290T3 (es) *	1994-04-28	1999-11-16	Takeda Chemical Industries Ltd	Metodo para separar componentes protectores de bordetella pertussis.
EP1233022B1 (de) *	1995-05-04	2015-12-09	Aventis Pasteur Limited	Verfahren zur Herstellung von Komponenten azellulären Pertussis-Impfstoffen
US5877298A (en) *	1995-05-04	1999-03-02	Connaught Lab	Acellular pertussis vaccines and methods of preparing thereof
JP3745805B2 (ja) *	1995-10-24	2006-02-15	日本ケミカルリサーチ株式会社	トロンボモジュリンの精製方法
US5739313A (en)	1995-11-13	1998-04-14	Regents Of The University Of Minnesota	Radionuclide labeling of vitamin B12 and coenzymes thereof
ES2262181T3 (es) *	1996-05-31	2006-11-16	National University Of Ireland, Maynooth	Il-12 como adyuvante en la vacuna contra la especie bordetella pertussis.
AU714493B2 (en)	1996-07-02	2000-01-06	Connaught Laboratories Limited	Multivalent DTP-polio vaccines
ES2322945T5 (es) *	2001-12-21	2012-10-17	Immunex Corporation	Métodos para purficación de proteína
WO2009016651A1 (en) *	2007-07-31	2009-02-05	Panacea Biotec Limited	Simplified means for obtaining prn from bordetella pertussis
US8574589B2 (en)	2009-05-11	2013-11-05	Novartis Ag	Antigen purification process for pertactin antigen
CN102584958A (zh) *	2012-02-08	2012-07-18	北京天坛生物制品股份有限公司	百日咳杆菌69kd外膜蛋白的纯化方法
EA030749B1 (ru)	2013-03-08	2018-09-28	Янссен Вэксинс Энд Превеншн Б.В.	Бесклеточная противококлюшная вакцина
KR102426041B1 (ko) *	2017-08-01	2022-07-29	주식회사 녹십자	냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법
CN113151081A (zh) *	2021-04-21	2021-07-23	深圳市儿童医院	一种百日咳鲍特菌培养基及其制备方法
WO2024056508A1 (en)	2022-09-15	2024-03-21	Cube Biotech Gmbh	In vitro diagnostic method for detecting the presence of a target by using stabilized membrane proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8412207D0 (en) *	1984-05-12	1984-06-20	Wellcome Found	Antigenic preparations
US5237052A (en) *	1984-05-12	1993-08-17	Burroughs Wellcome Company	Antigenic preparations and isolation of such preparations
GB8807860D0 (en) *	1988-04-05	1988-05-05	Connaught Lab	Pertussis vaccine
US5101014A (en) *	1989-02-10	1992-03-31	United States Of America	Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5276142A (en) *	1989-12-11	1994-01-04	American Cyanamid Company	Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007416D0 (en) †	1990-04-02	1990-05-30	Wellcome Found	Expression of heterologous protein in yeast

1990
- 1990-04-04 GB GB909007657A patent/GB9007657D0/en active Pending
1991
- 1991-04-03 CA CA002079887A patent/CA2079887C/en not_active Expired - Lifetime
- 1991-04-03 JP JP3506712A patent/JP2549225B2/ja not_active Expired - Lifetime
- 1991-04-03 DE DE0761230T patent/DE761230T1/de active Pending
- 1991-04-03 DK DK91906730T patent/DK0527753T4/da active
- 1991-04-03 ES ES96202627T patent/ES2104535T1/es active Pending
- 1991-04-03 AT AT91906730T patent/ATE147754T1/de not_active IP Right Cessation
- 1991-04-03 WO PCT/CA1991/000110 patent/WO1991015505A1/en active IP Right Grant
- 1991-04-03 EP EP96202627A patent/EP0761230A3/de not_active Withdrawn
- 1991-04-03 EP EP91906730A patent/EP0527753B2/de not_active Expired - Lifetime
- 1991-04-03 ES ES91906730T patent/ES2088374T5/es not_active Expired - Lifetime
- 1991-04-03 DE DE69124235T patent/DE69124235T3/de not_active Expired - Lifetime
- 1991-04-03 DE DE0527753T patent/DE527753T1/de active Pending
1992
- 1992-11-06 US US07/930,595 patent/US5444159A/en not_active Expired - Lifetime
1995
- 1995-05-04 US US08/433,644 patent/US5667787A/en not_active Expired - Lifetime
1997
- 1997-03-07 GR GR970400453T patent/GR3022769T3/el unknown
- 1997-10-31 GR GR970300034T patent/GR970300034T1/el unknown

Also Published As

Publication number	Publication date
WO1991015505A1 (en)	1991-10-17
EP0527753A1 (de)	1993-02-24
DK0527753T3 (da)	1997-04-07
DK0527753T4 (da)	2004-03-22
EP0761230A2 (de)	1997-03-12
EP0761230A3 (de)	1999-01-20
DE761230T1 (de)	1997-09-25
ES2088374T5 (es)	2004-08-16
DE69124235T3 (de)	2004-06-03
JPH05506649A (ja)	1993-09-30
GR3022769T3 (en)	1997-06-30
ES2088374T1 (es)	1996-08-16
GR970300034T1 (en)	1997-10-31
ATE147754T1 (de)	1997-02-15
EP0527753B2 (de)	2003-12-17
ES2104535T1 (es)	1997-10-16
US5667787A (en)	1997-09-16
CA2079887C (en)	1998-06-23
US5444159A (en)	1995-08-22
JP2549225B2 (ja)	1996-10-30
DE527753T1 (de)	1996-11-28
DE69124235T2 (de)	1997-05-28
ES2088374T3 (es)	1997-05-16
CA2079887A1 (en)	1991-10-05
EP0527753B1 (de)	1997-01-15
GB9007657D0 (en)	1990-05-30

Publication	Publication Date	Title
DE69124235D1 (de)	1997-02-27	Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
LU91591I2 (fr)	2009-10-12	Combinaison d'antoxine diphtérique, d'anatoxine tétanique,d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine, d'agglutinogènes fimbriaux coquelucheux 2 et 3 et de virus poliomyélitique inactivé type1, type 2 et type 3 (Triaxis Polio)
ATE128628T1 (de)	1995-10-15	Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
LU90203I2 (fr)	1998-04-06	Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables
LU93036I2 (fr)	2016-06-21	Vaccin diphtérirque, tétanique, coquelucheux (composant acelluaire, et incluant fimbriae des types 2 et 3), de l'hépatite b (adnr), poliomyélitique (inactivé), et conjugué de l'haemophilus de type b (adsrobé)
KR920002790A (ko)	1992-02-28	보르데텔라 퍼투스시스에 의해 발병되는 질병을 예방하는데 유효한 백신 및 비백일해 백신 성분과 조합된 상기 백신으로 구성되는 다가성 백신
ES2359806T3 (es)	2011-05-27	Vacunas contra la tos ferina acelulares y procedimientos de preparación de las mismas.
BR9712917A (pt)	1999-12-07	Vacina pertussis acelular com toxóides diftérico e tetânico
DE3855442D1 (de)	1996-08-29	Verfahren zur Gewinnung von Schutzantigenen gegen Bordetella-Infektionen und toxische Prozesse
ATE96036T1 (de)	1993-11-15	Verfahren zum zuechten von bordetella-pertussis, ein pertussis-toxoid und ein pertussis-impfstoff.
AU6584690A (en)	1991-05-09	Purification of B.pertussis toxin and filamentous hemagglutinin antigen
ATE420951T1 (de)	2009-01-15	Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen
GB9611501D0 (en)	1996-08-07	Vaccine compositions
Bhandari et al.	1990	Testing of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine for freedom from abnormal toxicity

Legal Events

Date	Code	Title	Description
1997-05-22	8363	Opposition against the patent
1998-07-09	8327	Change in the person/name/address of the patent owner	Owner name: CONNAUGHT LABORATORIES, INC., SWIFTWATER, PA., US
1998-07-09	8328	Change in the person/name/address of the agent	Free format text: DERZEIT KEIN VERTRETER BESTELLT
2004-03-04	8366	Restricted maintained after opposition proceedings